Clinical trials in Madrid – page 114

3 294 clinical trials in Madrid, Spain across 24 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

Madrid at a glance

3 294

clinical trials

Research sites24

Quick filters

3 294 trials in Madrid

Open in trial search

Transitional cell carcinoma

Not yet recruiting

Study of Disitamab Vedotin alone or with Pembrolizumab in patients with locally advanced or metastatic urothelial cancer that expresses HER2

InvestigationalNo placebo

Study of Disitamab Vedotin alone or with Pembrolizumab in patients with locally advanced or metastatic urothelial cancer that expresses HER2

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Disitamab Vedotin
Sponsor:Seagen Inc.

Contact Research Centre

Systemic lupus erythematosus+1

Not yet recruiting

Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

Registered drugNo placebo

Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:CC-97540
Sponsor:Celgene Corp.

Contact Research Centre

Neoplasm malignant+1

Not yet recruiting

Study of WEF-001 safety and effectiveness in patients with advanced KRAS-mutant solid tumors

InvestigationalNo placebo

Study of WEF-001 safety and effectiveness in patients with advanced KRAS-mutant solid tumors

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:WEF-001
Sponsor:Auricula Biosciences Inc.

Contact Research Centre

Allodynia

Not yet recruiting

Safety and effectiveness study of PN6047 HCl in adults with peripheral neuropathic pain and mechanical allodynia

Investigational

Safety and effectiveness study of PN6047 HCl in adults with peripheral neuropathic pain and mechanical allodynia

Investigational

Spain

Participants:18–64 years · 65+ years
Sponsor:Pharmnovo AB

Contact Research Centre

Fallopian tube cancer+1

Not yet recruiting

Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

Registered drugNo placebo

Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Glatiramer Acetate
Sponsor:Torl Biotherapeutics LLC

Contact Research Centre

Endometriosis

Not yet recruiting

Study of cabergoline compared to dienogest and ethinylestradiol for reducing endometriosis symptoms and lesion size in women with confirmed endometriosis

Registered drugNo placebo

Study of cabergoline compared to dienogest and ethinylestradiol for reducing endometriosis symptoms and lesion size in women with confirmed endometriosis

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Cabergoline
Sponsor:Hospital Clinico San Carlos

Contact Research Centre

Dry eye

Not yet recruiting

Evaluation of Mesenchymal Stem Cell Eye Injections for Dry Eye Disease in Patients with Graft-versus-Host Disease Who Haven't Responded to Standard Treatments

InvestigationalNo placebo

Evaluation of Mesenchymal Stem Cell Eye Injections for Dry Eye Disease in Patients with Graft-versus-Host Disease Who Haven't Responded to Standard Treatments

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Allogeneic Adipose-Derived Adult Mesenchymal Stem Cells Expanded
Sponsor:Fundacion De Investigacion Biomedica De Salamanca

Contact Research Centre

Cardiac failure

Not yet recruiting

Study on COR-1167 for Patients with Worsening Heart Failure

Investigational

Study on COR-1167 for Patients with Worsening Heart Failure

Investigational

Spain

Participants:18–64 years · 65+ years
Sponsor:Corteria Pharmaceuticals

Contact Research Centre

Infertility female

Not yet recruiting

Study of Platelet-Rich Plasma and Growth Factors Given by Ovarian Injection to Women with Low Ovarian Reserve During IVF Treatment

Registered drug

Study of Platelet-Rich Plasma and Growth Factors Given by Ovarian Injection to Women with Low Ovarian Reserve During IVF Treatment

Registered drug

Spain

Participants:18–64 years
Substances:Platelet Concentrate
Sponsor:Ivi Alicante S.L.

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Evaluation of Datopotamab Deruxtecan in Patients with Non-Squamous Non-Small Cell Lung Cancer and Active Brain Metastases

Registered drugNo placebo

Evaluation of Datopotamab Deruxtecan in Patients with Non-Squamous Non-Small Cell Lung Cancer and Active Brain Metastases

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Paracetamol
Sponsor:Medica Scientia Innovation Research S.L.

Contact Research Centre

Neovascular age-related macular degeneration

Not yet recruiting

Long-term Safety and Effectiveness Evaluation of RGX-314 in Patients with Neovascular Age-related Macular Degeneration

InvestigationalNo placebo

Long-term Safety and Effectiveness Evaluation of RGX-314 in Patients with Neovascular Age-related Macular Degeneration

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Neoplasm

Not yet recruiting

Study of Valemetostat Tosylate with Drug Combination for Patients with Previously Treated Solid Tumors

InvestigationalNo placebo

Study of Valemetostat Tosylate with Drug Combination for Patients with Previously Treated Solid Tumors

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Datopotamab Deruxtecan
Sponsor:Daiichi Sankyo Inc.

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Madrid

What the registry says about research in the country

01 Autoimmune and Inflammatory Conditions

Investigating novel treatments for cutaneous lupus erythematosus and immune thrombocytopenia, with studies evaluating new therapeutic approaches to manage these challenging conditions.

Lupus skin manifestations
Platelet disorders
Immune system regulation

Research focuses on improving treatment outcomes and quality of life for patients with autoimmune disorders.

02 Metabolic and Endocrine Disorders

Clinical trials examining innovative therapies for Type 1 Diabetes in combination with weight management, targeting both glycemic control and obesity-related complications.

Diabetes management
Weight control
Metabolic health

Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.

03 Neurological Conditions

Breakthrough research in multiple sclerosis and acute ischemic stroke, exploring new therapeutic options for both pediatric and adult populations.

MS treatment in young patients
Stroke intervention
Neurological recovery

Focus on developing targeted treatments to improve neurological outcomes and patient care.

04 Infectious Disease Prevention

Comprehensive vaccine studies targeting respiratory syncytial virus, influenza, and herpes zoster, with particular attention to vulnerable populations.

Vaccine development
Immune response
Prevention strategies

Research aims to enhance protection against common and serious infectious diseases.

05 Oncology Research

Innovative studies in mantle cell lymphoma and bladder cancer, exploring combination therapies and targeted treatments to improve patient outcomes.

Lymphoma treatment
Bladder cancer therapy
Immunotherapy approaches

Focus on developing more effective and personalized cancer treatments.

Back to Spain All countries